|
Other links:
What is KM?
General Links
Pharma Links
KM Books
Feedback
| |
 |
 |
June
2001 Volume 19 Number 6 pp BE44 - BE46 Nature Biotechnology
The headache of knowledge management
John
Hodgson
John Hodgson
is Editor-at-Large at Nature Biotechnology.
Biotechnology companies face an elusive threat—how to handle what they
know.
Finding a profitable niche for biotechnology within health care and
agriculture is tricky enough if you are the CEO of a large,
well-established, and well-funded company, but spare a thought for the
beleaguered CEO of a younger business. His/her job is made much harder by
investors' demands for multi-fold returns on investments, the inability to
offer the salaries needed to attract the best employees, and the management
of a commodity that is intangible, volatile, and
difficult-to-handle—knowledge.
Biotechnology is undeniably part of the knowledge economy. Young
companies, in particular, may have few tangible assets other than their
specific and detailed knowledge of a given area of technology. Yet despite
its fundamental importance, knowledge often appears to be a highly
undervalued asset for many biotechnology companies.
A recent survey of UK life science companies indicated that although many
recognized the importance of effective knowledge management, few considered
that a deficiency in knowledge management would pose a business risk (see
Henderson
p. BE23). Ironically, younger companies were prone to holding this
attitude, perhaps because at this stage of their development other matters
(e.g., financing and staffing) seem more pressing. However, even when
managers did recognize the risk, they invested very little time in knowledge
management1.
The tip of the iceberg
Knowledge clearly creates corporate value—perhaps most tangibly and clearly
through the patent system. A granted patent converts intellectual activity
into a clearly defined commercial opportunity and thus tradable value. |
|
 |
 |
Furthermore,
patents are one of the few things that can't walk out of the door! The
biotechnology sector is in constant flux, and personnel and management
migrate from company to company. Companies recognize that a free flow of
information from the company can undermine its technical or commercial
position, and they apply sensible restrictions to the efflux of knowledge.
Contractual restrictions, such as the inclusion of non-compete or
confidentiality clauses in employment agreements, may prevent competitors
learning too much about a company's vital information, but they cannot
prevent the information lost with departing staff. Companies can enforce
policies limiting commenting to the media, and may permit only designated
(senior) staff to talk in detail with potential collaborators on research
programs and commercial activities.However, knowledge management in a biotechnology company must encompass
more than patent filings and staff "gagging". A company's information and
knowledge assets arise from many quarters—both internally and externally.
For example, an increasing reliance on outsourcing and data sharing
(particularly in genomics) means that much of the potential knowledge
resources are generated outside a company. However, whether from internal or
externally generated data, knowledge and information is held initially by
individuals and not the body corporate.
Knowledge harnessed
The end product of good knowledge management procedures is "harnessed"
knowledge—knowledge that can be readily put to use on behalf of all relevant
members of the company (and its clients). "Harnessed" knowledge is held
within an organization, but can be mobilized even after the originator has
departed. Patents are one good example, or a highly cross-referenced
database of expert advisors, or a searchable manual of specific laboratory
protocols.
Then there is "unheld" knowledge—information that a company does not
currently possess. Unheld knowledge assets could be subdivided into those
that are known to be held (or harnessed) elsewhere (e.g., a patent owned by
others) and those that are, in essence, unknown (e.g., well-kept trade
secrets or unexplored technical avenues). Unheld knowledge should not simply
be regarded as a black box. Companies should make a considerable effort to
try to define the knowledge that they lack, first so that they can
demonstrate awareness of their shortcomings, and second, so that they can
embark on a strategy for remedying them. |
|
 |
 |
Somewhere between
harnessed and unheld knowledge lies "unharnessed" knowledge. Unharnessed
knowledge exists temporarily somewhere within a company, but its value is
diminished because it has neither been shared with relevant personnel nor
lodged with the company. For example, unharnessed knowledge can sit with the
uncommunicative junior researcher whose insight holds the key to
understanding an important metabolic pathway, and with the self-centered
senior executive whose wealth of negotiating tips and tricks are not shared
with her deal-building staff.The balance of knowledge management requirements changes as a company
develops. In the startup phase, the few founding staff are concentrating
primarily on R&D, and informal exchange of information ensures that
knowledge is disseminated throughout the organization. However, small
companies have only a few "information miners", and may lack sufficient
market or competitor intelligence to adjust their commercial or research
strategy appropriately. The coherence and compactness of an early-stage firm
makes it relatively easy to disseminate knowledge among relevant employees.
By the same token, however, a small company does not have the resources to
try to fill its knowledge gaps. A small company, therefore, will find it
relatively easy to "harness" most of the knowledge it has, but the large
amount of "unheld" knowledge still represents a significant risk.
Late-stage companies may have more knowledge-gathering agents, but
because of their size often have difficulty mobilizing that knowledge within
the organization. Segmentation of functions and more rigid definitions of
responsibility can act as barriers to internal information flow. Unless
appropriate knowledge management systems are in place, a larger company runs
the risk of losing coherence. Collectively, the company's employees will be
able to reduce the amount of unheld knowledge, but if that intelligence
rests only with particular individuals or within departments, then the
company has failed to harness it optimally.
Negative knowledge
One of the most readily overlooked parts of a company's knowledge assets is
"negative knowledge"—a concept wholly familiar to most scientists. Science
proceeds, at least according to Popperian theory, on the basis of
accumulated negative knowledge: Experiments are designed to disprove various
alternative or competing lines of thought. Theories that stand up to such
experimental rigor represent "the current understanding" of the subject
under consideration. In biotechnology companies, the same principles are
applied with a level of stringency that is necessary to make commercial
decisions. Once a company embarks on its decided path—to take a compound
into animal testing or to seek financing in Asian markets, for instance—the
negative knowledge that underpins its decision may be forgotten. Indeed,
subsequent decisions may be taken on the basis of different parameters. |
|
 |
 |
Biotechnology
companies are reasonably good at projecting their "visions" and "strategies"
to the outside world. They identify, share, disseminate (or restrict as
necessary) the knowledge needed to drive their business forward. They invest
time and money in filing patents to protect this knowledge, helping to chart
their progress to success. These are all manifestations of a company's
"positive knowledge".However, much of corporate endeavor—like human endeavor in
general—progresses empirically. To either side of the well-lit path to
corporate success are the false trails and beaten paths tried but not taken.
This "negative knowledge" accumulates not only during R&D but also in
manufacturing and commercial interactions. A company with an effective
knowledge management process will be able to build a permanent body of
awareness of "negative knowledge"—those approaches that didn't work out as
hoped or anticipated. Insight gleaned from early disappointments is as
valuable as the rare moments of success: each product launched is a survivor
among thousands of failed new chemical entities; and for each
headline-making pharmaceutical deal, there are many rebuffs. Thus, there is
every reason for a company both to retain those hard lessons within its
corporate memory, and to withhold those lessons from competitors pursuing a
similar approach.
Elements of knowledge management
One measure of a company's ability to manage knowledge is the alacrity with
which it identifies and pursues "unheld" knowledge, and the efficiency with
which it converts "unharnessed" into "harnessed" knowledge.
In a company that has its knowledge management systems under control, "unharnessed"
knowledge has only a fleeting existence—during that brief period before the
new research finding or commercial tidbit (previously "unheld" knowledge)
becomes "harnessed" for the company's benefit. Inadequate knowledge
management results in short-lived "unharnessed" knowledge becoming "unheld"
knowledge, and remaining in this intellectual "purgatory" before being
rediscovered at a much later date.
The first step in instituting effective knowledge management procedures
has to be the recognition by senior management that knowledge does not
simply just flow unbidden into or around organizations, any more than money
does. A company's CEO or chief financial officer is charged with the task
(among others) of identifying cash needs and actively seeking ways of
supplying them. The knowledge systems in the company should operate in much
the same way. |
|
 |
 |
Just as a company
would draw up a budget by discussing the financial needs of its various
function, so it should establish information and knowledge needs through a
formal process that involves departmental and group heads as well as the
senior management. That process defines not only what knowledge is needed
and who should endeavor to garner it, but also who needs to be informed
subsequently. That definition will lead to a description of a knowledge
management system, almost certainly intranet-based, that both helps fulfill
individual information needs and in effect monitors the company's collective
knowledge store.That process of defining the information needs will help employees
understand better their role in the knowledge machine that is the company
they work for. For instance, researchers understand that the results of
their experiments are important to the company. However, if they have come
from academic backgrounds, they may be less clear on what they can say about
their own work at scientific meetings or what might be of interest in other
people's presentations. A company's management can clarify these
definitions, and provide, through the knowledge management system, a
reporting outlet that will channel information around the organization.
Clearly, much of the information generated in a company is not needed by
all employees. Information flows need to be filtered so that raw data from
every microtiter plate well or the notes from the day's sales calls do not
obscure more important messages.
A knowledge management system does not have be burdensome: indeed, if it
is, it will not be used. The system will also encompass natural hierarchical
information flows. Research staff will naturally inform their group leaders
of progress and significant developments; sales and marketing staff speak
with their supervisors about new leads. But a knowledge management system
will help ensure that that occurs consistently. It will also contain
triggers and alerting mechanisms that draw out information that might not
otherwise be forthcoming.
Equally importantly, a knowledge management system needs to have an
element of self-sustainability. Management can urge or incentivize employees
to use the knowledge management apparatus, but the greatest encouragement
will arise when an employee finds something in it that is useful or vital to
him or her.
Knowledge management may not be at the top of most companies' lists of
business risks, but deficiencies in knowledge management erode the
performance of biotechnology companies' distinguishing assets—their
intellectual engines. In essence, then, the ideal knowledge management
system for a biotechnology company needs to combine the properties of a
black hole with those of a small sun: it draws information and knowledge
toward it but then re-emits it in appropriate beneficent doses in a variety
of directions. |
|
 |
 |
REFERENCES
- Arthur Andersen. Managing risk, building value: risk management in
the UK life sciences. (Arthur Andersen, London, UK, 2001).
Copyright 2001 Nature Publishing Group |
| |
|